Sun Pharmaceuticals (SUN) Acquires Organon & Co for $11.75 Billion

Sun Pharmaceuticals (SUN) announced an agreement to acquire Organon & Co for $11.75 billion, marking the largest overseas acquisition by an Indian company in nearly 20 years. This deal is part of a broader trend, with 162 Indian companies investing over $18 billion in outbound acquisitions in 2025, reflecting a 34% year-over-year increase. Notable acquisitions include Tata Motors' $4.4 billion purchase and IT firm Coforge's $2.35 billion acquisition. Analysts suggest that Indian firms are increasingly seeking overseas assets for strategic rather than merely symbolic reasons.